Thank you, Richard. Good morning. And thank you all for joining us to discuss our first quarter results of 2022. I am speaking from Hong Kong this evening, which is 12 hours ahead of Boston time. And hopefully, my home connection is good. I must say, I'm very happy to be able to travel again and to meet with customers, which is so important in developing our business. On my way home, I will be streamed by the 2022society of Information Displays Ossid Trade Show, which is taking place in early May in San Jose. Turning to that form of business, we are pleased with the results of the first quarter of 2022. Overall, year-over-year revenue was flat as our product sales were lowered. They were offset by our strong funded research and development revenues. Our product revenues were affected by the global supply chain issued. Particularly during the last couple of weeks of the quarter. As a result, were 12% or 14% lower than one of last year. In the past few quarter earning costs, we have mentioned our concern of the global supply chain production issues. While 14% year-over-year decline in product revenues is not something that we're pleased with given the circumstances we're are now, we're also not discouraged about it. Demand for our products remains strong. Let me explain why this issue is challenging to deal with. Because we make very complex components and its assembly -- assemblies, which going into extremely sophisticated interdependent defense in the industrial systems, we cannot simply switch a component just to ensure supply with another component. When we identify an issue and see a need to switch to a different component, we must notify our customer, displaying our plan, and in most cases have to obtain their formal approval. Then we must perform extensive testing on our revised product to ensure its compliances with the specifications, and provide the testing results to our customers for their review. Then our customer may be required to perform extensive system testing and obtain their own customer's approval. This process is time consuming. It means, that in addition to our normal development activities, we must allocate resources to identify replacement components and perform additional testing. Inspite, of all this, we were able to achieve relatively high level of manufacturing, while allocating resources to address these historic issues, and also make progress in our development activities, which are really crucial to our long-term growth. This why overall, we're satisfied with the first-quarter results. We continually to actively manage the supply chain issues. And while we expect intermittent supply chain disruptions of [Indiscernible] materials, we will have sufficient components to continue our 2022 growth over 2021. As we had previously discussed in the fourth quarter 2021, we announced new orders of our current production program, F-35, and our major weapon sight program. [Indiscernible], this gives us a strong foundation for 2022 product revenues. Looking out into the future of our current programs, we received feedback that the very unfortunate situation in Ukraine may eventually result to more product demand. Turning to our Organic Light-Emitting Diode [Indiscernible] Our briefing press release indicated we're making good progress in building this business. As discussed in the press release, we release that we received production order for our 2000 -- for our 2720p lightening OLED [Indiscernible] displays. And in other cases, a foundry customer is buying out [Indiscernible] Paulett Wafers, which are the fundamental building block to make OLED display. We believe these two new orders are [Indiscernible] to the competitive advantage of [Indiscernible] silicon backplane design and display performance, and also validates the power of [Indiscernible] business model. Under our model, we either sell finished OLED displays to our customers, working with our OLED foundry partners or we sell a [Indiscernible] wafers to our OLED OEM partners who complete the micro displays for sale to their own customer base. This business model provides us a lot of visibility to meet customer demands without incurring the major fixed capital investment associated with our lead deposition process. We continue to work on design wins with other new customers. Regarding to our research and development programs. We continue to make excellent progress on our customer funded defense development programs, which include armored vehicle targeting systems, rotary wing aircraft, pilot helmets, and additional weapon sight programs. We expect the rotary wing program to go to production in the second half of this year and armored vehicle program to go to production after 2023. Perhaps it is important to point out the breadth of the scope of our defense business. As a reminder, Kopin provides advanced back warded space, optics and rugged, dust free assemblies. For fighter JETS, such as F35 or rotary wing air-crafts, we provide displays. For gun sites, we provide displays, optics, and module assemblies. Now, for armored vehicles, we actually provide the whole full system units that include displays, optics, electronics, etc., etc. Currently, all our defense business and enterprise business are based on events, LCD on silicon displays. However, we've been actively developing OLED-On-Silicon displays for over five years, and now one of the leading OLED-On-Silicon displays developers. I must mention [Indiscernible]. We have a longer termed development projects and just focus on Macro LED. LED macro displays has potential for super high brightness and low-power assumption -- consumptions, which can make them ideal for many applications, including see-through, augmented reality and mixed reality applications. In summary, customer demands is strong of all our core product groups, and we are actively managing our supply chain challenges. We will continue our momentum on innovating and advancing our technology for AR/VR and MR applications. We believe strong interest in the Meta verse is just getting started. And we feel we are very well positioned to capitalize on the opportunities it provides. We entered 2022 with very strong backlog of orders, and we believe 2022 will be another year of good growth. We're excited for the growth of coping as we see a wave of growing interest in AR/VR and MR product applications. Our technology advances and current [Indiscernible] conditions are very favorable. And we believe coping is very well-positioned to capitalize it. Finally, I would like to make a comment on the equity gain in Q1. As some of you know, coping is very strong in IPs with over 2,000 -- with over 200 patents and patent applications providing display optics and module assemblies. One of the IP monetization strategy is to license some of our IPs to startup companies. As -- and as a copy, as a part of a conversation, we often receive equities in the startups. We've completed a few of those transactions and our goal is to do more. Some of the early transactions are not going to a more mature stages. We're actually very excited with this IP business model. Now, we turn the call to Rich to discuss the financial aspects of the quarter and a full-year. Rich, go ahead.